EUVIMEDEUVIMED entdecken
Crossref

Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation

Aihong Yang, Xiaoyue Yi, Hongwei Zhang, Rui Shen, Xiaodi Kou

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Aihong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Butyrylcholinesterase, Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the increasing aging population, rational design of drugs for Alzheimer's disease (AD) treatment has become an important research area. Based on the multifunctional design strategy, four diosmetin derivatives ( 1 – 4 ) were designed, synthesized, and characterized by 1 H NMR, 13 C NMR, and MS. Docking study was firstly applied to substantiate the design strategies and then the biological activities including cholinesterase inhibition, metal chelation, antioxidation and β‐amyloid (Aβ) aggregation inhibition in vitro were evaluated. The results showed that 1–4 had good acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition, metal chelation (selective chelation of Cu 2+ ions), antioxidation, self‐induced, Cu 2+ ‐induced, and AChE‐induced Aβ aggregation inhibition activities, and suitable blood–brain barrier (BBB) permeability. Especially, compound 3 had the strongest inhibitory effect on AChE (10 −8 M magnitude) and BuChE (10 −7 M magnitude) and showed the best inhibition on AChE‐induced Aβ aggregation with 66.14% inhibition ratio. Furthermore, compound 3 could also reduce intracellular reactive oxygen species (ROS) levels in Caenorhabditis elegans and had lower cytotoxicity. In summary, 3 might be considered as a potential multifunctional anti‐AD ligand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseAlzheimer DiseaseAmyloid beta-PeptidesDrug DesignCaenorhabditis elegansMolecular Docking SimulationBlood-Brain BarrierReactive Oxygen SpeciesFlavonoidsAnimalsLigandsHumansAntioxidantsStructure-Activity RelationshipProtein Aggregates

Stichwörter der Autor:innen

Alzheimer's diseasediosmetin derivativesmetal dyshomeostasismultifunctional ligand strategy

Substanzen

Cholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseAmyloid beta-PeptidesLigandsReactive Oxygen SpeciesdiosmetinFlavonoidsAntioxidantsProtein Aggregates

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Zitieren

APA

Yang, A., Yi, X., Zhang, H., Shen, R., & Kou, X. (2024). Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14529

Vancouver

Yang A, Yi X, Zhang H, Shen R, Kou X. Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14529

BibTeX
@article{Yang2024,
  author = {Yang, Aihong and Yi, Xiaoyue and Zhang, Hongwei and Shen, Rui and Kou, Xiaodi},
  title = {Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14529}
}
Kostenlos starten →